The revenue from antiretroviral drug formulations of Aurobindo Pharma Limited in fiscal year 2023 was over nine billion Indian rupees. This value was a significant increase from the previous financial year 2022.
Revenue from antiretroviral drug formulations by Aurobindo Pharma Limited from financial year 2013 to 2023
(in billion Indian rupees)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Aurobindo Pharma. (August 1, 2023). Revenue from antiretroviral drug formulations by Aurobindo Pharma Limited from financial year 2013 to 2023 (in billion Indian rupees) [Graph]. In Statista. Retrieved September 20, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/statistics/996262/india-aurobindo-pharma-arv-formulations-revenue/
Aurobindo Pharma. "Revenue from antiretroviral drug formulations by Aurobindo Pharma Limited from financial year 2013 to 2023 (in billion Indian rupees)." Chart. August 1, 2023. Statista. Accessed September 20, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/996262/india-aurobindo-pharma-arv-formulations-revenue/
Aurobindo Pharma. (2023). Revenue from antiretroviral drug formulations by Aurobindo Pharma Limited from financial year 2013 to 2023 (in billion Indian rupees). Statista. Statista Inc.. Accessed: September 20, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/996262/india-aurobindo-pharma-arv-formulations-revenue/
Aurobindo Pharma. "Revenue from Antiretroviral Drug Formulations by Aurobindo Pharma Limited from Financial Year 2013 to 2023 (in Billion Indian Rupees)." Statista, Statista Inc., 1 Aug 2023, https://www-statista-com.ezproxy.canberra.edu.au/statistics/996262/india-aurobindo-pharma-arv-formulations-revenue/
Aurobindo Pharma, Revenue from antiretroviral drug formulations by Aurobindo Pharma Limited from financial year 2013 to 2023 (in billion Indian rupees) Statista, https://www-statista-com.ezproxy.canberra.edu.au/statistics/996262/india-aurobindo-pharma-arv-formulations-revenue/ (last visited September 20, 2024)
Revenue from antiretroviral drug formulations by Aurobindo Pharma Limited from financial year 2013 to 2023 (in billion Indian rupees) [Graph], Aurobindo Pharma, August 1, 2023. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/statistics/996262/india-aurobindo-pharma-arv-formulations-revenue/